SCHEMBL890992

SCHEMBL890992

CCC(S)C(S)C(C)S

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17017292 1.00
SCHEMBL18327197 1.00
SCHEMBL17017291 1.00
SCHEMBL1445577 0.81
SCHEMBL28367279 0.79
SCHEMBL1059901 0.76
SCHEMBL149026 0.74
SCHEMBL891118 0.73
SCHEMBL2302733 0.71
Hydrochloric Acid SCHEMBL11620402 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170335007-A1 ANTI-CD39 ANTIBODIES AND USES THEREOF IGENICA BIOTHERAPEUTICS, INC. 2017-11-23 US disclosed
US-20160369005-A1 ANTI-C10ORF54 ANTIBODIES AND USES THEREOF PIERRE FABRE MEDICAMENT (FR) 2016-12-22 US disclosed
US-20160367699-A1 NOVEL LINKERS FOR ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE SENSEI BIOTHERAPEUTICS, INC. 2016-12-22 US disclosed
US-20160369005-A1 ANTI-C10ORF54 ANTIBODIES AND USES THEREOF PIERRE FABRE MEDICAMENT (FR) 2016-12-22 US disclosed
US-20160130349-A1 MODIFIED ANTIBODIES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Magenta Therapeutics, Inc. 2016-05-12 US disclosed
US-20160025716-A1 MULTISIGNAL LABELING REAGENTS AND PROCESSES AND USES THEREFOR Enzo Life Science, Inc., c/o Enzo Biochem, Inc. (US) 2016-01-28 US disclosed
WO-2014197849-A9 ANTI-C10ORF54 ANTIBODIES AND USES THEREOF IGENICA BIOTHERAPEUTICS, INC. (US) 2015-12-23 WO disclosed
US-9156986-B2 Multisignal labeling reagents and processes and uses therefor ENZO LIFE SCIENCES, INC. (US) 2015-10-13 US disclosed
US-20150231240-A1 ANTI-C16ORF54 ANTIBODIES AND METHODS OF USE THEREOF IGENICA BIOTHERAPEUTICS, INC. (US) 2015-08-20 US disclosed
WO-2014197854-A1 NOVEL LINKERS FOR ANTIBODY-DRUG CONJUGATES AND RELATED COMPOUNDS, COMPOSITIONS, AND METHODS OF USE IGENICA BIOTHERAPEUTICS, INC. (US) 2014-12-11 WO disclosed
US-20120082793-A1 DISPERSOID HAVING METAL-OXYGEN BONDS, METAL OXIDE FILM, AND MONOMOLECULAR FILM NIPPON SODA CO., LTD. (JP) 2012-04-05 US disclosed
EP-1422197-B1 DISPERSED INGREDIENT HAVING HAVING METAL- OXYGEN NIPPON SODA CO (JP) 2012-01-11 EP disclosed
US-20110135878-A1 Dispersoid having metal-oxygen bonds, metal oxide film, and monomolecular film NIPPON SODA, CO., LTD. (JP) 2011-06-09 US disclosed
US-7909929-B2 Dispersoid having metal-oxygen bonds, metal oxide film, and monomolecular film NIPPON SODA CO., LTD. (JP) 2011-03-22 US disclosed
US-7741376-B2 Process for preparing dispersed ingredient having metal-oxygen bonds NIPPON SODA CO., LTD. (JP) 2010-06-22 US disclosed
US-20090143498-A1 PROCESS FOR PREPARING DISPERSED INGEDIENT HAVING METAL-OXYGEN BONDS NIPPON SODA CO., LTD (JP) 2009-06-04 US disclosed
US-20060239902-A1 Dispersoid having metal-oxygen bonds, metal oxide film, and monomolecular film NIPPON SODA CO., LTD. (JP) 2006-10-26 US disclosed
EP-1580164-A1 DISPERSOID HAVING METAL-OXYGEN BOND, METAL OXIDE FILM, AND MONOMOLECULAR FILM NIPPON SODA CO., LTD. (JP) 2005-09-28 EP disclosed
US-20040197254-A1 Dispersed ingredient having metal-oxygen NIPPON SODA CO., LTD. (JP) 2004-10-07 US disclosed
EP-1422197-A1 DISPERSED INGREDIENT HAVING METAL&amp;minus;OXYGEN NIPPON SODA CO., LTD. (JP) 2004-05-26 EP disclosed